AI And TechnologyWaystar's continued investment in AI and new product introductions are highly likely to resonate with health system customers, driving market share gains.
Financial PerformanceWaystar's strong margin and cash flow profile support reinvestment in the platform, with the pending acquisition of Iodine expected to be financially accretive.
Revenue GrowthWaystar is well positioned to continue to produce low-double-digit organic sales growth through strong client retention, product innovation, and market share gains.